Transarterial chemoembolization for hepatocellular carcinoma in Fontan surgery patient.
18F-FDG, 2-deoxy-2-[fluorine-18]fluoro- D-glucose
Cardiac cirrhosis
Congenital heart disease
DSA, Digital Subtraction Angiography
Fontan operation
HCC, hepatocellular carcinoma
Hepatocellular carcinoma
PET-CT, positron emission tomography
TACE, Trans Arterial ChemoEmbolization
US, ultrasound
ceCT, contrast enhanced Computed Tomography
trans-arterial embolization
Journal
Radiology case reports
ISSN: 1930-0433
Titre abrégé: Radiol Case Rep
Pays: Netherlands
ID NLM: 101467888
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
18
08
2020
revised:
29
09
2020
accepted:
30
09
2020
entrez:
22
10
2020
pubmed:
23
10
2020
medline:
23
10
2020
Statut:
epublish
Résumé
We describe the case of a 41-year-old woman who developed a liver neoplasm due to previous Fontan surgery for a single ventricle anomaly and pacemaker implantation. She was admitted to our hospital for moderate ascites and she was affected by hepatocellular carcinoma treated by trans-arterial chemoembolization (TACE). Computed tomography showed features of chronic liver disease and 4 cm hepatic nodules with arterial enhancement. Laboratory analyses documented preserved liver function and increased levels of alpha-fetoprotein. TACE was performed obtaining complete necrosis at 4 weeks of follow up and significant reduction of alpha-fetoprotein after 2 months. The patient is currently in follow-up, being evaluated for further treatments and/or combined liver/heart transplantation. TACE is a therapeutic option for the treatment of patients with unresectable HCC and with severe heart disease, like those submitted to FS.
Identifiants
pubmed: 33088372
doi: 10.1016/j.radcr.2020.09.056
pii: S1930-0433(20)30518-5
pmc: PMC7557894
doi:
Types de publication
Case Reports
Langues
eng
Pagination
2602-2606Informations de copyright
© 2020 The Authors. Published by Elsevier Inc. on behalf of University of Washington.
Déclaration de conflit d'intérêts
Corresponding authors declare no conflict of interest for all the other authors.
Références
Heart. 2010 Nov;96(21):1750-5
pubmed: 20956491
J Hepatol. 2020 Apr;72(4):702-710
pubmed: 31726116
Insights Imaging. 2018 Jun;9(3):357-367
pubmed: 29623675
N Engl J Med. 2013 May 2;368(18):1756-7
pubmed: 23635071
J Am Coll Cardiol. 2017 Dec 26;70(25):3173-3194
pubmed: 29268929
Curr Probl Diagn Radiol. 2018 Jan - Feb;47(1):19-22
pubmed: 28602501
Tumour Biol. 2015 Dec;36(12):9857-64
pubmed: 26162540
Semin Liver Dis. 1999;19(3):329-38
pubmed: 10518312
Medicine (Baltimore). 2019 Aug;98(31):e16557
pubmed: 31374020
Hepatology. 2012 Sep;56(3):1160-9
pubmed: 22383293
Hepatology. 2019 Feb;69(2):911-913
pubmed: 30055116